← Back to Search

Enhanced Usual Care for Opioid Cessation (STOP Trial)

N/A

Waitlist Available

Led By Jennifer Hah, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled for total hip, knee, or shoulder replacement

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

STOP Trial Summary

This trial will compare two methods for helping people quit opioids after hip or knee surgery.

Who is the study for?

This trial is for English-speaking adults who are planning to undergo hip, knee, or shoulder replacement surgery and have used opioids before and after the operation. They should be willing to complete surveys and not currently under a pain specialist's care. People with high suicide risk, pregnant individuals, those unable to do assessments, or in another perioperative study can't join.Check my eligibility

What is being tested?

The study compares two approaches: 'enhanced usual care' versus 'motivational interviewing with guided opioid tapering support', aiming to help patients stop using opioids after their joint replacement surgeries.See study design

What are the potential side effects?

While specific side effects aren't listed for motivational interviewing or enhanced usual care, participants may experience discomfort from discussing personal issues related to opioid use during interviews.

STOP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a hip, knee, or shoulder replacement surgery.

STOP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time to Opioid Cessation

Secondary outcome measures

Opioid Misuse

Side effects data

From 2015 Phase 3 trial • 203 Patients • NCT01325714

13%

Deceased - Unrelated to Study

100%

80%

60%

40%

20%

Study treatment Arm

Arm 2: Enhanced Usual Care

Arm 1: PAVeD Intervention

STOP Trial Design

2Treatment groups

Experimental Treatment

Group I: Motivational Interviewing and Guided Opioid Tapering SupportExperimental Treatment1 Intervention

Group II: Enhanced Usual CareExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Enhanced Usual Care

2019

Completed Phase 3

~8530

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,472 Previous Clinical Trials

2,619,172 Total Patients Enrolled

Stanford UniversityLead Sponsor

2,396 Previous Clinical Trials

17,341,105 Total Patients Enrolled

1 Trials studying Opioid Cessation

104 Patients Enrolled for Opioid Cessation

Jennifer Hah, MDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any participants being enrolled in this investigation at present?

"According to clinicaltrials.gov, enrollment into this medical trial has been paused since June 6th 2022 – the last time it was edited on the database. However, 1 other research project is currently in need of volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation

Jennifer Hah 2019. "Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03659734.

All > Opiate Addiction